title: A comparison of failure modes of glutaraldehyde-treated versus antibiotic-preserved mitral valve allografts implanted in sheep.
abstract: Morphologic studies and calcium analyses were made on mitral valve allografts from 12 juvenile sheep surviving 12 to 24 weeks after mitral valve replacement. Before implantation, the allografts were treated with 0.625% glutaraldehyde (group I, n = 4) or with cold antibiotic solution (group II, n = 8). Three group I animals died 12 to 19 weeks after implantation because of dysfunction of calcified valves; the surviving animal also had extensive allograft calcification. One group II animal died of mitral regurgitation; the valves of the other seven (including five with regurgitation shown by Doppler and ventriculographic studies) were explanted at 19 to 24 weeks. Chordal rupture related to calcific deposits was found in all group I valves. Leaflet perforations (n = 4) and ruptured chordae (n = 4), each caused by connective tissue deterioration, were found in group II valves. Inflammatory reaction was absent or minimal in group I valves but moderate or severe in group II valves. Fibrous sheaths were thicker in group II than in group I valves. Calcium levels were much higher in group I than in group II valves. Calcification in group I valves was diffuse and involved collagen, elastic fibers, and connective tissue cells and matrix; in group II valves, it was localized in connective tissue cells. Thus glutaraldehyde-treated allografts failed because of extensive calcification, whereas antibiotic-preserved allografts underwent deterioration of connective tissue and infiltration by inflammatory cells.
authors.affiliation: Pathology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md. 20892, USA.
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: M
authors.initials: M
authors.lastname: Jones
authors.forename: I
authors.initials: I
authors.lastname: Yamada
authors.forename: V J
authors.initials: VJ
authors.lastname: Ferrans
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001705:Bioprosthesis; D002114:Calcinosis / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D002815:Chordae Tendineae / Q000473:pathology; D003094:Collagen / Q000187:drug effects / Q000648:ultrastructure; D004727:Endothelium / Q000648:ultrastructure; D005260:Female; D005976:Glutaral / Q000494:pharmacology*; D006084:Graft Rejection / Q000209:etiology*; D006350:Heart Valve Prosthesis; D008297:Male; D008854:Microscopy, Electron; D008943:Mitral Valve / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000637:transplantation*; D011183:Postoperative Complications / Q000209:etiology*; D011475:Prosthesis Failure; D011859:Radiography; D012756:Sheep; D014021:Tissue Preservation / Q000379:methods*; D014184:Transplantation, Homologous
chemical_list: D000900:Anti-Bacterial Agents; D003094:Collagen; D002118:Calcium; D005976:Glutaral